GGrantIndex
← Leaderboards

Metrohealth Medical Center

Cleveland, OH

Compare ↔
$4,976,704
Total funding
10
Grants

Funding over time

peak $448.4K · FY200515
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$4,976,704 · 9
AHRQ$0 · 1

By mechanism

R01$3,906,009 · 4
R00$709,586 · 1
R03$151,000 · 2
R29$124,722 · 1
F32$85,387 · 2

Investigators at Metrohealth Medical Center

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

Largest grants

Role of Molecular Chaperones in hERG Processing$337,500
R01 · FY2004 · HL
Role of Molecular Chaperones in hERG Processing$337,500
R01 · FY2005 · HL
Role of Molecular Chaperones in hERG Processing$329,570
R01 · FY2006 · HL
Role of Molecular Chaperones in hERG Processing$320,012
R01 · FY2008 · HL
Role of Molecular Chaperones in hERG Processing$320,012
R01 · FY2007 · HL
Molecular Studies of Brain Malformations$311,643
R01 · FY2004 · HD
REGULATION OF AP 2 AND HER 2/NEU GENE PROMOTERS$276,771
R01 · FY2000 · CA
REGULATION OF AP 2 AND HER 2/NEU GENE PROMOTERS$265,557
R01 · FY2003 · CA
REGULATION OF AP 2 AND HER 2/NEU GENE PROMOTERS$257,820
R01 · FY2002 · CA
REGULATION OF AP 2 AND HER 2/NEU GENE PROMOTERS$250,310
R01 · FY2001 · CA
Maternal obesity depresses essential fatty acid transport in the placenta$249,734
R00 · FY2013 · HD
Maternal obesity depresses essential fatty acid transport in the placenta$234,603
R00 · FY2015 · HD
NEURONAL MIGRATION IN THE DEVELOPING BRAIN$227,250
R01 · FY2003 · NS
NEURONAL MIGRATION IN THE DEVELOPING BRAIN$227,250
R01 · FY2002 · NS
NEURONAL MIGRATION IN THE DEVELOPING BRAIN$227,250
R01 · FY2001 · NS
Maternal obesity depresses essential fatty acid transport in the placenta$225,249
R00 · FY2014 · HD
NEURONAL MIGRATION IN THE DEVELOPING BRAIN$217,564
R01 · FY2000 · NS
TRANSCRIPTIONAL INTERFERENCE AND TUMORIGENICITY$124,722
R29 · FY2000 · CA
Molecular mechanism of chemoprevention by benzylistothiocyanate in pancreatic can$75,500
R03 · FY2008 · CA
Molecular mechanism of chemoprevention by benzylistothiocyanate in pancreatic can$75,500
R03 · FY2009 · CA